16.06.2026
... & Johnson JNJ 235.66 -2.16% Merck Co. 6MK 114.9 -3.49% Chevron ...
15.06.2026
... Dysphagie, leiden. Mavenclad®, die von Merck KGaA entwickelte orale Cladribin-MS ...
13.06.2026
... 0,05%, MorphoSys 0%, Lanxess -1,05%, Merck Co. -1,44%, Sanofi -1,74%, ... Sartorius -2,32%, Valneva -2,47%, Merck KGaA -2,63%, Gilead Sciences -2,76 ...
13.06.2026
... % Rocket Internet RKET 25 -1.57% Merck KGaA MRK 133.25 -1.59 ...
13.06.2026
... % Hannover Rück HNR1 228.2 -1.21% Merck KGaA MRK 133.25 -1.59 ...